Copyright Reports & Markets. All rights reserved.

Global Myocardial Perfusion Imaging Testing Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Myocardial Perfusion Imaging Testing Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Single Photon Emission Computed Tomography
    • 1.3.3 Positron Emission Tomography
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Myocardial Perfusion Imaging Testing Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospital
    • 1.4.3 Ambulatory Care Centers
    • 1.4.4 Others
  • 1.5 Global Myocardial Perfusion Imaging Testing Market Size & Forecast
    • 1.5.1 Global Myocardial Perfusion Imaging Testing Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Myocardial Perfusion Imaging Testing Sales Quantity (2020-2031)
    • 1.5.3 Global Myocardial Perfusion Imaging Testing Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Lantheus
    • 2.1.1 Lantheus Details
    • 2.1.2 Lantheus Major Business
    • 2.1.3 Lantheus Myocardial Perfusion Imaging Testing Product and Services
    • 2.1.4 Lantheus Myocardial Perfusion Imaging Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Lantheus Recent Developments/Updates
  • 2.2 Cardinal Health
    • 2.2.1 Cardinal Health Details
    • 2.2.2 Cardinal Health Major Business
    • 2.2.3 Cardinal Health Myocardial Perfusion Imaging Testing Product and Services
    • 2.2.4 Cardinal Health Myocardial Perfusion Imaging Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Cardinal Health Recent Developments/Updates
  • 2.3 GE Healthcare
    • 2.3.1 GE Healthcare Details
    • 2.3.2 GE Healthcare Major Business
    • 2.3.3 GE Healthcare Myocardial Perfusion Imaging Testing Product and Services
    • 2.3.4 GE Healthcare Myocardial Perfusion Imaging Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 GE Healthcare Recent Developments/Updates
  • 2.4 Pharmalucence
    • 2.4.1 Pharmalucence Details
    • 2.4.2 Pharmalucence Major Business
    • 2.4.3 Pharmalucence Myocardial Perfusion Imaging Testing Product and Services
    • 2.4.4 Pharmalucence Myocardial Perfusion Imaging Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Pharmalucence Recent Developments/Updates
  • 2.5 Curium Pharma
    • 2.5.1 Curium Pharma Details
    • 2.5.2 Curium Pharma Major Business
    • 2.5.3 Curium Pharma Myocardial Perfusion Imaging Testing Product and Services
    • 2.5.4 Curium Pharma Myocardial Perfusion Imaging Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Curium Pharma Recent Developments/Updates
  • 2.6 Jubilant DraxImage
    • 2.6.1 Jubilant DraxImage Details
    • 2.6.2 Jubilant DraxImage Major Business
    • 2.6.3 Jubilant DraxImage Myocardial Perfusion Imaging Testing Product and Services
    • 2.6.4 Jubilant DraxImage Myocardial Perfusion Imaging Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Jubilant DraxImage Recent Developments/Updates
  • 2.7 Atom-Hitech
    • 2.7.1 Atom-Hitech Details
    • 2.7.2 Atom-Hitech Major Business
    • 2.7.3 Atom-Hitech Myocardial Perfusion Imaging Testing Product and Services
    • 2.7.4 Atom-Hitech Myocardial Perfusion Imaging Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Atom-Hitech Recent Developments/Updates
  • 2.8 Dongcheng Biochemicals
    • 2.8.1 Dongcheng Biochemicals Details
    • 2.8.2 Dongcheng Biochemicals Major Business
    • 2.8.3 Dongcheng Biochemicals Myocardial Perfusion Imaging Testing Product and Services
    • 2.8.4 Dongcheng Biochemicals Myocardial Perfusion Imaging Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Dongcheng Biochemicals Recent Developments/Updates
  • 2.9 Jiangyuan Pharmaceutical
    • 2.9.1 Jiangyuan Pharmaceutical Details
    • 2.9.2 Jiangyuan Pharmaceutical Major Business
    • 2.9.3 Jiangyuan Pharmaceutical Myocardial Perfusion Imaging Testing Product and Services
    • 2.9.4 Jiangyuan Pharmaceutical Myocardial Perfusion Imaging Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Jiangyuan Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Myocardial Perfusion Imaging Testing by Manufacturer

  • 3.1 Global Myocardial Perfusion Imaging Testing Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Myocardial Perfusion Imaging Testing Revenue by Manufacturer (2020-2025)
  • 3.3 Global Myocardial Perfusion Imaging Testing Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Myocardial Perfusion Imaging Testing by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Myocardial Perfusion Imaging Testing Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Myocardial Perfusion Imaging Testing Manufacturer Market Share in 2024
  • 3.5 Myocardial Perfusion Imaging Testing Market: Overall Company Footprint Analysis
    • 3.5.1 Myocardial Perfusion Imaging Testing Market: Region Footprint
    • 3.5.2 Myocardial Perfusion Imaging Testing Market: Company Product Type Footprint
    • 3.5.3 Myocardial Perfusion Imaging Testing Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Myocardial Perfusion Imaging Testing Market Size by Region
    • 4.1.1 Global Myocardial Perfusion Imaging Testing Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Myocardial Perfusion Imaging Testing Consumption Value by Region (2020-2031)
    • 4.1.3 Global Myocardial Perfusion Imaging Testing Average Price by Region (2020-2031)
  • 4.2 North America Myocardial Perfusion Imaging Testing Consumption Value (2020-2031)
  • 4.3 Europe Myocardial Perfusion Imaging Testing Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Myocardial Perfusion Imaging Testing Consumption Value (2020-2031)
  • 4.5 South America Myocardial Perfusion Imaging Testing Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Myocardial Perfusion Imaging Testing Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Myocardial Perfusion Imaging Testing Sales Quantity by Type (2020-2031)
  • 5.2 Global Myocardial Perfusion Imaging Testing Consumption Value by Type (2020-2031)
  • 5.3 Global Myocardial Perfusion Imaging Testing Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Myocardial Perfusion Imaging Testing Sales Quantity by Application (2020-2031)
  • 6.2 Global Myocardial Perfusion Imaging Testing Consumption Value by Application (2020-2031)
  • 6.3 Global Myocardial Perfusion Imaging Testing Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Myocardial Perfusion Imaging Testing Sales Quantity by Type (2020-2031)
  • 7.2 North America Myocardial Perfusion Imaging Testing Sales Quantity by Application (2020-2031)
  • 7.3 North America Myocardial Perfusion Imaging Testing Market Size by Country
    • 7.3.1 North America Myocardial Perfusion Imaging Testing Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Myocardial Perfusion Imaging Testing Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Myocardial Perfusion Imaging Testing Sales Quantity by Type (2020-2031)
  • 8.2 Europe Myocardial Perfusion Imaging Testing Sales Quantity by Application (2020-2031)
  • 8.3 Europe Myocardial Perfusion Imaging Testing Market Size by Country
    • 8.3.1 Europe Myocardial Perfusion Imaging Testing Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Myocardial Perfusion Imaging Testing Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Myocardial Perfusion Imaging Testing Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Myocardial Perfusion Imaging Testing Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Myocardial Perfusion Imaging Testing Market Size by Region
    • 9.3.1 Asia-Pacific Myocardial Perfusion Imaging Testing Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Myocardial Perfusion Imaging Testing Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Myocardial Perfusion Imaging Testing Sales Quantity by Type (2020-2031)
  • 10.2 South America Myocardial Perfusion Imaging Testing Sales Quantity by Application (2020-2031)
  • 10.3 South America Myocardial Perfusion Imaging Testing Market Size by Country
    • 10.3.1 South America Myocardial Perfusion Imaging Testing Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Myocardial Perfusion Imaging Testing Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Myocardial Perfusion Imaging Testing Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Myocardial Perfusion Imaging Testing Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Myocardial Perfusion Imaging Testing Market Size by Country
    • 11.3.1 Middle East & Africa Myocardial Perfusion Imaging Testing Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Myocardial Perfusion Imaging Testing Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Myocardial Perfusion Imaging Testing Market Drivers
  • 12.2 Myocardial Perfusion Imaging Testing Market Restraints
  • 12.3 Myocardial Perfusion Imaging Testing Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Myocardial Perfusion Imaging Testing and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Myocardial Perfusion Imaging Testing
  • 13.3 Myocardial Perfusion Imaging Testing Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Myocardial Perfusion Imaging Testing Typical Distributors
  • 14.3 Myocardial Perfusion Imaging Testing Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Myocardial Perfusion Imaging Testing market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Myocardial Perfusion Imaging Testing market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Myocardial Perfusion Imaging Testing market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Myocardial Perfusion Imaging Testing market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Myocardial Perfusion Imaging Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Myocardial Perfusion Imaging Testing market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Myocardial Perfusion Imaging Testing
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Myocardial Perfusion Imaging Testing market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lantheus, Cardinal Health, GE Healthcare, Pharmalucence, Curium Pharma, Jubilant DraxImage, Atom-Hitech, Dongcheng Biochemicals, Jiangyuan Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Myocardial Perfusion Imaging Testing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Single Photon Emission Computed Tomography
    Positron Emission Tomography
    Market segment by Application
    Hospital
    Ambulatory Care Centers
    Others
    Major players covered
    Lantheus
    Cardinal Health
    GE Healthcare
    Pharmalucence
    Curium Pharma
    Jubilant DraxImage
    Atom-Hitech
    Dongcheng Biochemicals
    Jiangyuan Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Myocardial Perfusion Imaging Testing product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Myocardial Perfusion Imaging Testing, with price, sales quantity, revenue, and global market share of Myocardial Perfusion Imaging Testing from 2020 to 2025.
    Chapter 3, the Myocardial Perfusion Imaging Testing competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Myocardial Perfusion Imaging Testing breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Myocardial Perfusion Imaging Testing market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Myocardial Perfusion Imaging Testing.
    Chapter 14 and 15, to describe Myocardial Perfusion Imaging Testing sales channel, distributors, customers, research findings and conclusion.

    Buy now